Category Archives: J. CONDITIONS TO TREAT

Acupuncture: Complementary or alternative blood pressure therapy?

When Tufts|ebcam reviewed this topic, they concluded, “while the results of some RCT [randomized clinical trials] and case series suggest some benefits of acupuncture for managing hypertension, the results must be treated with caution because of serious methodological limitations.”

To address these shortcomings the NIH funded a rigorously designed study titled “Stop Hypertension with the Acupuncture Research Program” (SHARP).

Continue reading Acupuncture: Complementary or alternative blood pressure therapy? →

Self-care for peripheral neuropathy in HIV/AIDS

Peripheral neuropathy is the most common neurological complication in HIV, and it’s often associated with antiretroviral therapy. Patients experience muscle weakness and atrophy, pain, and numbness.

Here’s what people use to manage the discomfort. Continue reading Self-care for peripheral neuropathy in HIV/AIDS →

Zinc supplements in patients with head and neck cancer

Here’s a report (see page 113) from the 2007 Multidisciplinary Head and Neck Cancer Symposium.

Researchers at the North Central Cancer Treatment Group (NCCTG) conducted a double-blind, placebo-controlled trial to determine the value of zinc in preventing taste alterations (dysgeusia) in patients with head and neck cancer who were undergoing radiation therapy.

Here are the details.

  • 169 patients randomly assigned to zinc sulfate 45 mg by mouth 3 times/day, vs placebo administered throughout radiation to the posterior oropharynx and for one month after.
  • 81% of patients experienced taste alterations: 61 of those taking zinc and 71 taking placebo.
  • Time to taste alteration was 2.3 weeks with zinc vs 1.6 weeks in the placebo arm.

Although patients taking zinc had a delay in the onset of altered taste, the difference was not statistically significant. Therefore, the researchers concluded that zinc at the doses studied failed to prevent taste alterations in patients undergoing radiation-based treatment regimens for head and neck cancer.

The results differ from an earlier study in patients with dysgeusia that was not associated with cancer or other diseases.

3/10/07 14:42 JR

Evaluating omega-3 polyunsaturated fatty acid supplementation for joint pain

A literature review by two researchers at York University in Toronto “suggest[s] that omega-3 PUFAs are an attractive adjunctive treatment for joint pain associated with rheumatoid arthritis, inflammatory bowel disease, and dysmenorrhea [painful menstruation].”

Results were positive for most measures of outcome.

Continue reading Evaluating omega-3 polyunsaturated fatty acid supplementation for joint pain →

Update on an FDA warning about “natural alternatives” to treat impotence

Last year, the FDA warned consumers not to buy or use 7 supplements that were sold online to treat impotence and enhance sexual performance.

All but one are still marketed either by the same name or a different name. So, I’ve restated the warning with an update on the new names.

  • Zimaxx contains sildenafil (Viagra): Now called Zimaxx 2000.

The rest contain vardenafil, the active ingredient in Levitra, another prescription drug used to treat erectile dysfunction or impotence.

  • Libidus: Now called Maxidus
  • Neophase: Continues to be sold by that name
  • Nasutra: Now called Kama Sutra Rx
  • Vigor-25: Now called Rize 2
  • Actra-Rx: Now called Actra-Sx
  • 4Everon: Doesn’t appear to be sold anymore

You can’t be sure that the “new” products eliminated the Viagra or Levitra from their formualtions.

The problem is that consumers may not know that these ingredients can interact with medications and dangerously lower their blood pressure.

7/13/06 10:25 JR Updated 3/6/07 00:22 JR